Previous 10 | Next 10 |
LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) is pleased to announce they are launching two new and improved formulas for its top selling product, Vitastem and Vitastem Ultra. The original Vitastem is an FDA-registered drug a...
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website reporting Convertible Notes Payable of $281,538.00 and a Convertible Line of Credit of...
LOS ANGELES, June 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update on current business activities. The Company has finalized a ten-year $12 million licensing agreement in Dubai. Under the terms of the agreement ...
LOS ANGELES, June 02, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have expanded their current licensing agreement with a home health wound care network. Per the agreement, ViaDerma receives $5000 per month for each state i...
LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an initial order for the Company’s wound care product, Vitastem. The healthcar...
For 1Q21, ViaDerma (VDRM) estimates revenues to top $113K compared to total revenues of only $2,133 for year ago quarter mainly led by $90K proceeds from a earlier announced licensing agreement.Revenues from online retail sales for Q1 are estimated to be more than $23K (+978% Y/Y).The company...
LOS ANGELES, April 08, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update of estimated sales and revenue numbers for the first quarter of 2021, as well as additional highlights of the Company’s year to date progress. ...
LOS ANGELES, March 16, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to announce they have paid off all outstanding toxic convertible debt and the Company is now completely debt free. The total debt amounted to more than $869,900 and w...
LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical practices. The medical practices provide advanced wound care treatment to homebound pati...
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his expectations for the coming year 2021. “Despite the challenges f...
News, Short Squeeze, Breakout and More Instantly...
ViaDerma Inc Company Name:
VDRM Stock Symbol:
OTCMKTS Market:
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC:VDRM) is pleased to announce several new and exciting business update...
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM ) is pleased to announce several new and exciting business updates for current and prospective shareholders, customers, partners, and healthcare providers. The company is currently in the final phases of...
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is very pleased to announce several exciting business updates for current and prospective shareholders, partners, and healthcare providers. The company is currently over 30% through the process of our stability t...